Should Resistance Testing Be Performed for Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness Analysis

This publication has 37 references indexed in Scilit:

• Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
  The Journal of Infectious Diseases, 2005
• Treatment for Adult HIV Infection
  JAMA, 2004
• Drug‐Selected Resistance Mutations and Non‐B Subtypes in Antiretroviral‐Naive Adults with Established Human Immunodeficiency Virus Infection
  The Journal of Infectious Diseases, 2003
• Sequencing to NRTI plus NNRTI-Only Combinations After Virological Failure of Protease Inhibitor-Based Combination HIV-1 Therapy
  HIV Research & Clinical Practice, 2003
• Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS
  Medical Decision Making, 2002
• The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
  New England Journal of Medicine, 2001
• The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine
  AIDS, 2000
• Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults
  New England Journal of Medicine, 1999
• The ALBI Trial: A Randomized Controlled Trial Comparing Stavudine Plus Didanosine with Zidovudine Plus Lamivudine and a Regimen Alternating Both Combinations in Previously Untreated Patients Infected with Human Immunodeficiency Virus
  The Journal of Infectious Diseases, 1999
• Preventing Mycobacterium avium complex in patients who are using protease inhibitors
  AIDS, 1998